Form 4: Agilent Director Sells 2,600 Shares in Pre-Planned Transaction

Agilent Technologies Director Mikael Dolsten sold 2,600 shares of common stock for approximately $149.81 per share as part of a pre-arranged trading plan.

Summary

• Mikael Dolsten, a Director of Agilent Technologies, Inc. (A), sold 2,600 shares of common stock.
• The transaction occurred on December 1, 2025.
• The shares were sold at a weighted average price of $149.812, with individual sales ranging from $149.80 to $149.84.
• Following the sale, Mr. Dolsten beneficially owns 4,973.028 shares of Agilent common stock.
• This transaction was executed pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-scheduled.
• The remaining beneficial ownership includes 23.092 shares acquired under the Agilent Technologies, Inc. dividend reinvestment plan, which have been deferred.

Sentiment

Score: 5

Explanation: The sale of shares by a director, even if pre-planned under a 10b5-1 plan, can be viewed neutrally to slightly negatively by the market as it reduces insider ownership. However, the pre-planned nature mitigates immediate negative sentiment.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned sale rather than a reactive decision based on recent company performance or news.

Negatives

• A director selling shares, even if pre-planned, can sometimes be perceived as a slight negative signal by investors, indicating a reduction in insider exposure.

Risks

• No specific risks are mentioned in the filing beyond the inherent market risk associated with holding equity.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The Reporting Person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information directly related to broader industry trends or competitive landscape. Insider sales are a routine part of executive compensation and personal financial planning, especially when executed under pre-arranged Rule 10b5-1 plans.

Corporate Governance

Stakeholder Impact

• Shareholders: May interpret the director's sale as a slight reduction in insider confidence, though the 10b5-1 plan mitigates this. The transparency of the filing provides insight into insider activity.
• Regulatory Authorities: The filing ensures compliance with Section 16(a) of the Exchange Act, providing transparency on insider transactions.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned insider sale by a director under a Rule 10b5-1 plan. Such transactions are typically for personal financial management and do not inherently signal a change in the company's fundamental outlook or performance. While a sale reduces insider ownership, the pre-scheduled nature means it's not a reactive move. Therefore, based solely on this filing, there is no strong signal to alter an investment position, warranting a 'hold' recommendation.

Keywords

Agilent Technologies, Mikael Dolsten, Insider Sale, Form 4, Director Transaction, A Stock, Rule 10b5-1, Common Stock